本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Larimar Therapeutics, Inc.

3.12
-0.4300-12.11%
成交量:272.69萬
成交額:904.62萬
市值:2.67億
市盈率:-1.60
高:3.56
開:3.56
低:3.12
收:3.55
52周最高:6.91
52周最低:1.61
股本:8,559.04萬
流通股本:4,514.94萬
量比:1.47
換手率:6.04%
股息:- -
股息率:- -
每股收益(TTM):-1.9534
每股收益(LYR):-1.3159
淨資產收益率:-78.24%
總資產收益率:-42.99%
市淨率:1.92
市盈率(LYR):-2.37

資料載入中...

2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/08

重要事件披露

8-K - Current report
2020/11/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/12

重要事件披露

8-K/A [Amend] - Current report
2020/11/10

重要事件披露

8-K - Current report
2020/10/30

重要事件披露

8-K - Current report
2020/10/02

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/09/29

重要事件披露

8-K/A [Amend] - Current report
2020/09/29

重要事件披露

8-K - Current report
2020/08/31

SEC問詢函

CORRESP [Cover] - Correspondence
2020/08/14

重要事件披露

8-K/A [Amend] - Current report
2020/08/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/11

重要事件披露

8-K - Current report